2022 | Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease | Lee, Ji Min; SHU-CHEN WEI ; Lee, Kang-Moon; Ye, Byong Duk; Mao, Ren; Kim, Hyun-Soo; Park, Soo Jung; Park, Sang Hyoung; Oh, Eun Hye; Im, Jong Pil; Jang, Byung Ik; Kim, Dae Bum; Takeuchi, Ken | Gut and liver | 7 | 7 | |
2020 | Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study | Yamamoto-Furusho, Jesus K; Al Harbi, Othman; Armuzzi, Alessandro; Chan, Webber; Ponce de Leon, Enrique; Qian, Jiaming; Shapina, Marina; Toruner, Murat; CHIA-HUNG TU ; Ye, Byong Duk; Guennec, Morgane; Sison, Cecilia; Demuth, Dirk; Fadeeva, Olga; Khan, Qasim M Rana | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 10 | | |